|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de la Chapelle A: Genetic predisposition
to colorectal cancer. Nat Rev Cancer. 4:769–780. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Knowlton AA and Srivatsa U: Heat-shock
protein 60 and cardiovascular disease: A paradoxical role. Future
Cardiol. 4:151–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hansen JJ, Durr A, Cournu-Rebeix I,
Georgopoulos C, Ang D, Nielsen MN, Davoine CS, Brice A, Fontaine B,
Gregersen N and Bross P: Hereditary spastic paraplegia SPG13 is
associated with a mutation in the gene encoding the mitochondrial
chaperonin Hsp60. Am J Hum Genet. 70:1328–1332. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grundtman C and Wick G: The autoimmune
concept of atherosclerosis. Curr Opin Lipidol. 22:327–334. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Li X, Zhang W, Chen Y, Zhu S, Chen
L, Xu R, Lv Y, Wu D, Guo M, et al: HSP60-regulated mitochondrial
proteostasis and protein translation promote tumor growth of
ovarian cancer. Sci Rep. 9:126282019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cappello F, Conway DME, Marasa L, Zummo G
and Macario AJ: Hsp60 expression, new locations, functions and
perspectives for cancer diagnosis and therapy. Cancer Biol Ther.
7:801–809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghosh JC, Dohi T, Kang BH and Altieri DC:
Hsp60 regulation of tumor cell apoptosis. J Biol Chem.
283:5188–5194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai YP, Yang MH, Huang CH, Chang SY, Chen
PM, Liu CJ, Teng SC and Wu KJ: Interaction between HSP60 and
beta-catenin promotes metastasis. Carcinogenesis. 30:1049–1057.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghosh JC, Siegelin MD, Dohi T and Altieri
DC: Heat shock protein 60 regulation of the mitochondrial
permeability transition pore in tumor cells. Cancer Res.
70:8988–8993. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cappello F, Bellafiore M, Palma A, David
S, Marciano V, Bartolotta T, Sciume C, Modica G, Farina F, Zummo G
and Bucchieri F: 60KDa chaperonin (HSP60) is over-expressed during
colorectal carcinogenesis. Eur J Histochem. 47:105–110. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang H, Chen Y, Liu X, Wang S, Lv Y, Wu D,
Wang Q, Luo M and Deng H: Downregulation of HSP60 disrupts
mitochondrial proteostasis to promote tumorigenesis and progression
in clear cell renal cell carcinoma. Oncotarget. 7:38822–38834.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Teng R, Liu Z, Tang H, Zhang W, Chen Y, Xu
R, Chen L, Song J, Liu X and Deng H: HSP60 silencing promotes
Warburg-like phenotypes and switches the mitochondrial function
from ATP production to biosynthesis in ccRCC cells. Redox Biol.
24:1012182019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hjerpe E, Egyhazi S, Carlson J, Stolt MF,
Schedvins K, Johansson H, Shoshan M and Avall-Lundqvist E: HSP60
predicts survival in advanced serous ovarian cancer. Int J Gynecol
Cancer. 23:448–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cappello F, Rappa F, David S, Anzalone R
and Zummo G: Immunohistochemical evaluation of PCNA, p53, HSP60,
HSP10 and MUC-2 presence and expression in prostate carcinogenesis.
Anticancer Res. 23:1325–1331. 2003.PubMed/NCBI
|
|
17
|
Boston University Research Support, .
Carbon Dioxide Euthanasia for Rats and Mice (BU ASC Guidelines).
Boston University Research Support; Boston, MA: 2019, https://www.bu.edu/researchsupport/compliance/animal-care/working-with-animals/euthanasia/carbon-dioxide-euthanasia-for-rats-and-mice/Revised
May 2019.
|
|
18
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sánchez-González C, Nuevo-Tapioles C,
Herrero Martín JC, Pereira MP, Serrano Sanz S, Ramírez de Molina A,
Cuezva JM and Formentini L: Dysfunctional oxidative phosphorylation
shunts branched-chain amino acid catabolism onto lipogenesis in
skeletal muscle. EMBO J. 39:e1038122020. View Article : Google Scholar
|
|
20
|
Zaborske JM, Narasimhan J, Jiang L, Wek
SA, Dittmar KA, Freimoser F, Pan T and Wek RC: Genome-wide analysis
of tRNA charging and activation of the eIF2 kinase Gcn2p. J Biol
Chem. 284:25254–25267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mills GC, Schmalstieg FC, Trimmer KB,
Goldman AS and Goldblum RM: Purine metabolism in adenosine
deaminase deficiency. Proc Natl Acad Sci USA. 73:2867–2871. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeon SM: Regulation and function of AMPK
in physiology and diseases. Exp Mol Med. 48:e2452016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou C, Sun H, Zheng C, Gao J, Fu Q, Hu N,
Shao X, Zhou Y, Xiong J, Nie K, et al: Oncogenic HSP60 regulates
mitochondrial oxidative phosphorylation to support Erk1/2
activation during pancreatic cancer cell growth. Cell Death Dis.
9:1612018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang H, Li J, Liu X, Wang G, Luo M and
Deng H: Down-regulation of HSP60 suppresses the proliferation of
Glioblastoma cells via the ROS/AMPK/mTOR pathway. Sci Rep.
6:283882016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vocka M, Langer D, Fryba V, Petrtyl J,
Hanus T, Kalousova M, Zima T and Petruzelka L: Novel serum markers
HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer. Oncol
Lett. 18:6284–6292. 2019.PubMed/NCBI
|
